ABP 215 (Bevacizumab-awwb), a Bevacizumab biosimilar, is a humanized IgG1 monoclonal antibody targeting VEGFA. ABP 215 has anticancer effects, and can be used metastatic colorectal cancer (mCRC) research.
CAS号
1438851-35-4
中文名称
Bevacizumab beta
运输条件
Room temperature in continental US; may vary elsewhere.